Literature DB >> 16873970

Motor enrichment sustains hindlimb movement recovered after spinal cord injury and glial transplantation.

L D F Moon1, J L Leasure, F H Gage, M B Bunge.   

Abstract

PURPOSE: This study investigated whether enrichment improves hindlimb movement following complete spinal cord transection and transplantation of olfactory ensheathing glia (OEG), with or without a Schwann cell (SC) bridge.
METHODS: Motor activity was encouraged through provision of motor enrichment housing (MEH); a multi-level cage containing ramps, textured surfaces and rewards. Hindlimb joint movement was assessed weekly for 22 weeks starting one week post-surgery, comparing rats housed in MEH to those in basic housing (BH). Transganglionic tracer was injected into the crushed right sciatic nerve three days prior to sacrifice, allowing sensory axons in the dorsal columns to be visualized by immunolabeling. Serotonergic axons and glial cells expressing low affinity nerve growth factor receptor were identified by immunolabeling.
RESULTS: All rats, having received transplants, recovered some hindlimb movement. Rats housed in BH progressively lost recovered hindlimb function whereas recovered hindlimb movements were sustained in most rats in MEH. In rats transplanted with SCs and OEG, effects of MEH were first significant 14 weeks after injury. In rats transplanted with OEG, a trend was seen from 14 weeks after injury, but this did not reach significance. In all rats, traced sensory axons died back from sites of transplantation and did not regenerate rostrally. Further, in no rat were serotonergic axons observed regenerating into, around or beyond transplants.
CONCLUSIONS: Transection and transplantation of SC/OEG or OEG induced recovery of hindlimb function. This recovered hindlimb movement was sustained in rats housed in MEH but was progressively lost in rats housed in BH. Because benefits of MEH were not observed until 14 weeks after injury, long-term assessment of behavior is recommended. BH conditions are not conducive to maintenance of recovered hindlimb function, and MEH should be used in studies of recovery of function following spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873970

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  9 in total

1.  Dissociated predegenerated peripheral nerve transplants for spinal cord injury repair: a comprehensive assessment of their effects on regeneration and functional recovery compared to Schwann cell transplants.

Authors:  Caitlin E Hill; Danika M Brodak; Mary Bartlett Bunge
Journal:  J Neurotrauma       Date:  2012-08-10       Impact factor: 5.269

2.  Analysis of olfactory ensheathing glia transplantation-induced repair of spinal cord injury by electrophysiological, behavioral, and histochemical methods in rats.

Authors:  Kai-Jun Liu; Jin Xu; Chang-Yu Yang; Han-Bo Chen; Xiang-Sheng Liu; Yong-Deng Li; Zhan-Fei Li
Journal:  J Mol Neurosci       Date:  2009-08-08       Impact factor: 3.444

Review 3.  Biomaterial design strategies for the treatment of spinal cord injuries.

Authors:  Karin S Straley; Cheryl Wong Po Foo; Sarah C Heilshorn
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

Review 4.  A systematic review of cellular transplantation therapies for spinal cord injury.

Authors:  Wolfram Tetzlaff; Elena B Okon; Soheila Karimi-Abdolrezaee; Caitlin E Hill; Joseph S Sparling; Jason R Plemel; Ward T Plunet; Eve C Tsai; Darryl Baptiste; Laura J Smithson; Michael D Kawaja; Michael G Fehlings; Brian K Kwon
Journal:  J Neurotrauma       Date:  2010-04-20       Impact factor: 5.269

Review 5.  Transplantation-mediated strategies to promote axonal regeneration following spinal cord injury.

Authors:  Xiao-Ming Xu; Stephen M Onifer
Journal:  Respir Physiol Neurobiol       Date:  2009-08-07       Impact factor: 1.931

Review 6.  Advances in regenerative therapies for spinal cord injury: a biomaterials approach.

Authors:  Magdalini Tsintou; Kyriakos Dalamagkas; Alexander Marcus Seifalian
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

7.  Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuries.

Authors:  Xiao-Ming Xu
Journal:  Neural Regen Res       Date:  2012-08-05       Impact factor: 5.135

8.  Low-pressure micro-mechanical re-adaptation device sustainably and effectively improves locomotor recovery from complete spinal cord injury.

Authors:  Veronica Estrada; Julia Krebbers; Christian Voss; Nicole Brazda; Heinrich Blazyca; Jennifer Illgen; Klaus Seide; Christian Jürgens; Jörg Müller; Rudolf Martini; Hoc Khiem Trieu; Hans Werner Müller
Journal:  Commun Biol       Date:  2018-11-26

9.  Refinement of the spinal cord injury rat model and validation of its applicability as a model for memory loss and chronic pain.

Authors:  V S Harikrishnan; Hamza Palekkodan; Ansar Fasaludeen; Lissy K Krishnan; Klas S P Abelson
Journal:  Heliyon       Date:  2021-07-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.